The 8th Complement-based Drug Development Summit covers topics such as:
- Quantifying Complement Levels with Sensitive & Specific Assays
- Correlation Vs. Causation: Does Complement Drive Disease Pathology or is it a Biological Response?
- What is the Best Fragment to Target; Positioning Complement Inhibitors Against Complement Inhibitors
- Investigating Sensitive & Specific Assays to Quantify Complement Levels in Tissues
- Optimizing Clinical Development Strategies to Ensure Commercial Success with Complement Therapeutics
- Mitigating Toxicity Effects of Immunosuppression with Complement Inhibitors
- New Modalities of Complement Therapeutics Demonstrating Clinical Promise
- Exploring the Non-Canonical Functions of Complement & Identifying Future Therapeutic Opportunities
The 8th Complement-based Drug Development Summit might be held in Dec 2024.